ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,080.58
-0.06%
Dow Jones
43,408.47
0.32%
Gold vs US Dollar
2,669.065
0.63%
Brent Oil
73.355
0.71%
Bitcoin
97,092.13
2.90%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Gsk Plc (GSK) Share Price

GSK Gsk Plc

1,304.50
4.50 (0.35%)
Last Updated: 08:39:59
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Gsk Plc LSE:GSK London Stock Exchange Ordinary Share GB00BN7SWP63 ORD 31 1/4P
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   4.50 0.35 1,304.50 1,304.50 1,305.00 1,309.50 1,300.00 1300 253,658 08:39:59   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations 30.33B 4.93B 1.1889 11.01 53.89B
 Type  Size  Price  Time  Units 
  153 1,304.65 08:40:18 GBX
 
Recent News
DateTimeSource
HeadlineMore GSK News
19/11/202415:30LSEG_RNSGSK PLC Director/PDMR Shareholding
19/11/202409:24ALNCGSK hails positive results for linerixibat in treating relentless itch
19/11/202409:24ALNCGSK hails positive results for linerixibat in treating relentless itch
19/11/202407:00LSEG_RNSGSK PLC GLISTEN Trial of Linerixibat Meets Endpoint
14/11/202408:54ALNCGSK hails survival results in blood cancer patients with Blenrep
14/11/202408:54ALNCGSK hails survival results in blood cancer patients with Blenrep
14/11/202407:00LSEG_RNSGSK PLC GSK announces overall survival results for Blenrep
Period
Draw mode
Latest Message Board Discussions
DateTimeSource
Title
Posts
21/11/202408:23PBBGlaxosmithkline - The recovery33,766
15/11/202410:28PBBGLAXOSMITHKLINE WITH CHARTS & NEWS192
15/11/202410:22PBBGSK74
10/10/202405:29PBBGlazoSmithKline - News & Information149
17/04/202318:25PBBGsk zantac2
28/02/202316:35PBBGSK launched Shingrix, which has a far superior shingles prevention effect1
01/09/202214:17PBBGSK - just mucking around4
23/01/202114:27PBBIn Rude Health!2
06/10/202015:28PBBcovid vaccines not needed.. Trump. Calls experimental drugs "miracles from god"3
31/03/202006:46PBBCOVID-19..downgraded no longer high consequence infectious disease1
Newsletter articles for Gsk Plc
DateTimeNewsletterHeadline
28/7/202213:55Tom Winnifrith's N50GSK – half-year update, what now after consumer health business demerger?
28/4/202207:21Tom Winnifrith's N50GlaxoSmithKline – Q1 update, further share price upside as demerger nears
01/3/202210:13Building an income portfolio with Clem ChambersIncome Investors Need To Be More Aggressive Now
24/2/202207:07Tom Winnifrith's N50GlaxoSmithKline – Consumer Healthcare business named and demerger “on track”, still not too late to Buy
11/2/202211:43Tom Winnifrith's N50GlaxoSmithKline – 2021 results, “strong commercial execution”?
29/7/202115:40Tom Winnifrith's N50GlaxoSmithKline – second quarter results, still a recovery buy
02/7/202112:53Tom Winnifrith's N50GlaxoSmithKline – a Recovery Buy
More newsletter articles
Data Downloads for GSK

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)
Technical Analysis for Gsk Plc
Get quick technical analysis for Gsk Plc.
Price Indicators
Evaluate in real-time the trend for this stock with base on twelve different studies.
Candlesticks
Verify the trend for the closing and opening times for this stock or defined reversal patterns.
Support & Resistance
Automatically plot the main lines for support and resistance for this tock highlighting the main levels.
Related Shares
Astrazeneca (AZN), Haleon (HLN), Fusion Antibodies (FAB), N4 Pharma (N4P)


Loading Follow Feed...

Latest Gsk Plc Articles

BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 60%* for Level 2 Lite

1 year 40%, 2 years 50% and *3 years 60%
EU Flag

*Across 3 years £2132.64 only £853.06